vimarsana.com

Sonnet BioTherapeutics Holdings Inc. (SONN) will implement a 1-for-22 reverse stock split of its outstanding common stock at the commencement of trading today. In premarket trading today, the stock is up over 2,300% at $4.

Related Keywords

,Sonnet Biotherapeutics Holdings Inc ,Nasdaq Capital ,Safety Monitoring Board ,Nasdaq ,Reverse Stock Split ,Neuropathy ,Bonn ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.